Projects
#3309Substances with Neuropharmacological Activity
Development of New Pharmacologically Active Substances Based on the Studies of Mycelium Fungi Secondary Metabolites Interaction with CNS Receptors
#3496Anti-Alzheimer’s Disease Agents
From Antidepressants and/or Monoamine Oxidase Inhibitors towards Anti-Alzheimer’s Disease Agents
Annual Reports
Annual Reports
The electronic version of the 2017 Annual Report
and2017 Audited Financial Reportis available by downloading the pdf file from this website
view